Cisplatin at Nearly Normal Levels, After FDA Taps Manufacturers to Reduce Cancer Drug Shortages

The FDA’s work with cancer drug manufacturers has brought the cisplatin supply back to nearly 100 percent of the pre-shortage levels, the White House said in an announcement on Tuesday.
Source: Drug Industry Daily